Carr Patricia (CIK 1784606) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-09). Recent activity: Sell JAZZ (1,436 shares), Sell JAZZ (1,287 shares), Buy JAZZ (2,223 shares), Sell JAZZ (1,253 shares), Sell JAZZ (1,117 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-09 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Sell | 1,436 | $268,202 |
| 2026-03-09 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Sell | 1,287 | $235,444 |
| 2026-03-02 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Buy | 2,223 | $0 |
| 2026-03-02 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Sell | 1,253 | $243,220 |
| 2026-03-02 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Sell | 1,117 | $213,246 |
| 2026-01-21 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Buy | 2,370 | $0 |
| 2025-12-09 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Sell | 160 | $27,378 |
| 2025-12-09 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Buy | 4,500 | $633,015 |
| 2025-12-09 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Sell | 4,500 | $770,400 |
| 2025-11-20 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Sell | 69 | $12,535 |
| 2025-11-20 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Buy | 5,250 | $714,945 |
| 2025-11-20 | Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Sell | 5,250 | $955,868 |
Source: SEC Form 4 filings · as of 2026-03-09